RBM47 has been shown to inhibit the progression of several malignancies, including thyroid carcinoma, nasopharyngeal carcinoma, lung cancer and colorectal cancer, whereas its role in PCa has not been characterized.30, 31, 32, 33. Here, RBM47 is linked to lung carcinoma.